BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6460092)

  • 1. Subacute myelo-optic neuropathy (SMON). First neuro-pathological report outside Japan.
    Ricoy JR; Ortega A; Cabello A
    J Neurol Sci; 1982 Feb; 53(2):241-51. PubMed ID: 6460092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals.
    Tateishi J
    Neuropathology; 2000 Sep; 20 Suppl():S20-4. PubMed ID: 11037182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMON as seen from Bombay.
    Wadia NH
    Acta Neurol Scand Suppl; 1984; 100():159-64. PubMed ID: 6091394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SMON: toxicity of clioquinol and the status quo].
    Konagaya M
    Brain Nerve; 2015 Jan; 67(1):49-62. PubMed ID: 25585435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?
    Schaumburg H; Herskovitz S
    Neurology; 2008 Aug; 71(9):622-3. PubMed ID: 18725588
    [No Abstract]   [Full Text] [Related]  

  • 6. Some thoughts on 'SMON'.
    Pallis C
    Acta Neurol Scand Suppl; 1984; 100():147-53. PubMed ID: 6237544
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical MRI of subacute myelo-optico-neuropathy.
    Kimura E; Hirano T; Yamashita S; Hirai T; Uchida Y; Maeda Y; Uchino M
    Spinal Cord; 2011 Feb; 49(2):182-5. PubMed ID: 20548321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropathology of subacute myelo-optico-neuropathy, "SMON", in the humans: --with special reference to the quinoform intoxication.
    Shiraki H
    Jpn J Med Sci Biol; 1975; 28 Suppl():101-64. PubMed ID: 136535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of myelo-optic neuropathy preceded by abdominal symptoms].
    Massons Cirera J; Zunzunegui Costas J; Titus Alvareda F
    Med Clin (Barc); 1983 Jun; 80(20):894-5. PubMed ID: 6224988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toward the complete understanding of the pathogenic mechanism of clioquinol-induced subacute myelo-optic neuropathy (SMON)].
    Katsuyama M
    Nihon Yakurigaku Zasshi; 2024; 159(2):78-82. PubMed ID: 38432923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SMON--a model of the iatrogenic disease].
    Takasu T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
    Selby G
    Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
    [No Abstract]   [Full Text] [Related]  

  • 13. Tongue strength in patients with subacute myelo-optico-neuropathy.
    Yamashita S; Nakama T; Ueda M; Honda S; Kimura E; Konagaya M; Ando Y
    J Clin Neurosci; 2018 Jan; 47():84-88. PubMed ID: 29054330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.
    Meade TW
    Br J Prev Soc Med; 1975 Sep; 29(3):157-69. PubMed ID: 127638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in patients with subacute myelo-optico-neuropathy (SMON).
    Konishi T; Hayashi K; Hayashi M; Ueno S; Yoshida S; Fujimura H; Funakawa I; Kaido M
    Intern Med; 2008; 47(24):2127-31. PubMed ID: 19075537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neurological evaluation of purported cases of SMON in Sweden.
    Gilland O
    Acta Neurol Scand Suppl; 1984; 100():165-9. PubMed ID: 6091395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica in the old age: a clinico-pathological contribution.
    Ghezzi M; Giansanti M; Malentacchi GM; Barontini F
    Ital J Neurol Sci; 1987 Dec; 8(6):613-6. PubMed ID: 3429221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.
    Egashira Y; Matsuyama H
    Acta Pathol Jpn; 1982; 32 Suppl 1():101-16. PubMed ID: 6316716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of halogenated hydroxyquinolines: non-Japanese cases.
    Thomas PK
    Acta Neurol Scand Suppl; 1984; 100():155-8. PubMed ID: 6091393
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenicity of virus associated with subacute myelo-optico-neuropathy.
    Nakamura Y; Inoue YK
    Lancet; 1972 Jan; 1(7744):223-6. PubMed ID: 4109698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.